Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRC

ABSTRACT: This phase II study aims to explore the efficacy and safety of fruquintinib combined with TAS-102 in the third-line treatment of patients with advanced metastatic colorectal cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2386605 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR